Despite trailing the broader market over the past year, Cigna Group still enjoys a strongly bullish long-term outlook from ...

The Cigna Group (NYSE:CI) is one of the best defensive stocks to invest in according to analysts. Cigna shares cracked over ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read an analysis of HUM stock now.

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Cigna, with a price target of $354.00. The company’s shares closed yesterday at $267.38. Take advantage of TipRanks ...

Cigna's recent market performance paints a complex picture, dropping 5.18% despite mixed analyst ratings. Institutional ...

In a report released today, Sarah James from Cantor Fitzgerald reiterated a Buy rating on Cigna, with a price target of $365.00. The company’s shares closed yesterday at $297.86. Take advantage of ...

Cigna Corporation faces a significant challenge with an 11.04% drop in its stock price, despite strong underlying ...

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the company supplies ...

UnitedHealth Group (UNH) came out with quarterly earnings of $4.08 per share, missing the Zacks Consensus Estimate of $4.84 per share. This compares to earnings of $6.8 per share a year ago. These ...

Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds that impacted UnitedHealth ...

Shares of Cigna Group CI tumbled 10.23% to $267.38 Thursday, on what proved to be an all-around grim trading session for the ...

Wells Fargo analyst Stephen Baxter on Thursday expressed surprise at The Cigna Group (CI) stock trading in the red, while ...